Novartis Portugal Revenue and Competitors
Estimated Revenue & Valuation
- Novartis Portugal's estimated annual revenue is currently $22.7M per year.
- Novartis Portugal's estimated revenue per employee is $201,000
Employee Data
- Novartis Portugal has 113 Employees.
- Novartis Portugal grew their employee count by 9% last year.
Novartis Portugal's People
Name | Title | Email/Phone |
---|
Novartis Portugal Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $151.8M | 755 | 11% | N/A | N/A |
#6 | $63.9M | 318 | 13% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $1.7M | 17 | -6% | $114.3M | N/A |
#9 | $6.8M | 34 | -6% | N/A | N/A |
#10 | $12.5M | 62 | -9% | N/A | N/A |
What Is Novartis Portugal?
Estamos a reimaginar a medicina para melhorar e prolongar a vida das pessoas. Como uma empresa global líder em medicamentos, usamos a ciência inovadora e tecnologias digitais para criar terapêuticas transformadoras em áreas com grandes necessidades médicas. Em Portugal, a nossa equipa tem 350 pessoas e estamos sediados no Taguspark, em Porto Salvo. Consulte aqui as Normas da Comunidade: http://bit.ly/NormasLinkedInNovartispt Aviso de Privacidade páginas de LinkedIn: http://bit.ly/AvisoPrivNovartisPT
keywords:N/AN/A
Total Funding
113
Number of Employees
$22.7M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Novartis Portugal News
2022-04-20 - Telix Pharmaceuticals : Appendix 4C and Activities Report for March 2022
quarter
3 Novartis release 23 March 2022. ... Greece and Cyprus (BIOKOSMOS S.A.), Poland (Synektik Pharma Sp. Zo. o), Portugal (Avanço), Sweden,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15.8M | 113 | 24% | N/A |
#2 | $24.9M | 113 | 57% | N/A |
#3 | $16.5M | 118 | 39% | N/A |
#4 | $23.9M | 133 | 8% | N/A |
#5 | $18.6M | 133 | 22% | N/A |